According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

A new charity football team in Peterborough has been set up to honour the memory of Jordan Smith and raise awareness of ...

Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... Landmark Study Involving Babies in Ireland Supports Use of Cystic Fibrosis Drug in ...

SION-2851 is under development for the treatment of cystic fibrosis. It is a small molecule administered orally. It is a first generation corrector. The drug candidate targets cystic fibrosis ...

LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...

Coughing is a natural reflex action that helps clear the airways of irritants, mucus, smoke, dust, or allergens. While most ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Sophie Pierce is determined to make the most of her life - however long she may have.

The new series of Room to Improve will see Dermot Bannon travel to Co Mayo as he helps transform a derelict property into a ...

Stockard has completed the interview portion of the competition and is now preparing for on-stage competition, which, for her, begins Wednesday.

A $42,000 grant from NASA and INBRE will further CF research, through a collaborative effort spanning to India and the United Kingdom.